A Budget Impact Analysis (Bia) Of The Use Of Paricalcitol For The Treatment Of Secondary Hyperparathyroidism (Shpt) In End Stage Renal Disease Patients
Abstract
Authors
V. Lorenzoni F. Pierotti G. Turchetti
V. Lorenzoni F. Pierotti G. Turchetti
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now